EyePoint (EYPT) Common Equity (2011 - 2026)
EyePoint's Common Equity was $166.41 million in Q2 2026, down 32.4% from $246.01 million a year earlier and down 27.8% from the prior quarter.
Powered by 
Analysis
EyePoint (EYPT) Common Equity (2011 - 2026) Analysis & Trends
At the end of FY2025, Common Equity at EyePoint came in at $306.11 million, down 9.0% from FY2024.
- Common Equity shows a five-year compound annual growth rate of 75.2% (FY2020 to FY2025).
- In earlier years, Common Equity was $336.5 million in FY2024 (+26.4%), $266.32 million in FY2023 (+176.4%), $96.37 million in FY2022 (-47.7%) and $184.38 million in FY2021 (+894.4%).
- The Q2 2026 figure marks the lowest quarterly Common Equity since Q3 2023.
- Compared with a year earlier, Common Equity has declined for four straight quarters, with growth averaging 31.7% over the last eight quarters.
- The best year-over-year quarter for Common Equity over five years was Q4 2021 (growth of 894.4%); the worst was Q2 2023 (a decline of 62.2%).
- Per Business Quant data, EYPT's Common Equity in the three quarters before Q2 2026 was $230.47 million (Q1 2026), $306.11 million (Q4 2025) and $200.18 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | EyePoint | 281.29 Mn | -631.84 Mn | 507,000.00 | 166.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 166.41 Mn |
| Mar 31, 2026 | 230.47 Mn |
| Dec 31, 2025 | 306.11 Mn |
| Sep 30, 2025 | 200.18 Mn |
| Jun 30, 2025 | 246.01 Mn |
| Mar 31, 2025 | 298.40 Mn |
| Dec 31, 2024 | 336.50 Mn |
| Sep 30, 2024 | 218.73 Mn |
| Jun 30, 2024 | 228.31 Mn |
| Mar 31, 2024 | 249.93 Mn |
| Dec 31, 2023 | 266.32 Mn |
| Sep 30, 2023 | 58.62 Mn |
| Jun 30, 2023 | 57.26 Mn |
| Mar 31, 2023 | 78.39 Mn |
| Dec 31, 2022 | 96.37 Mn |
| Sep 30, 2022 | 136.35 Mn |
| Jun 30, 2022 | 151.37 Mn |
| Mar 31, 2022 | 166.82 Mn |
| Dec 31, 2021 | 184.38 Mn |
| Sep 30, 2021 | 92.75 Mn |
API Access
EyePoint Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=EYPT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "EYPT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=EYPT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();